Market stimulus and genomic justice: Evaluating the effects of market access to human germ-line enhancement

Kennedy Institute of Ethics Journal

Volumn 20, Issue 2, 2010, Pages 161-179

  Crozier, G K D ^a   Hajzler, Christopher ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ETHICS; GENETIC ENHANCEMENT; HEALTH CARE DELIVERY; HUMAN; HUMAN GENOME; SOCIAL JUSTICE; SOCIOECONOMICS;

GENETIC ENHANCEMENT; GENOME, HUMAN; HEALTH SERVICES ACCESSIBILITY; HUMANS; SOCIAL JUSTICE; SOCIOECONOMIC FACTORS;

EID: 77954715127     PISSN: 10546863     EISSN: 10863249     Source Type: Journal    
DOI: 10.1353/ken.0.0310     Document Type: Article

References (35)

1. Arrow, Kenneth. 1969. Classifcatory Notes on the Production and Transmission of Technological Knowledge. American Economic Review 59(2):29-35.
2. Beschizza, Rob. 2007. $200 Ubuntu Linux PC Now Available at Wal-Mart. Wired Blog Network (31 October). Available at http://blog.wired.com/ gadgets/2007/10/200-everex-gree.html, accessed 23 April 2010.
3. Buchanan, Allen. 1995. Equal Opportunity and Genetic Intervention. Social Philosophy and Policy 12(2):105-35.
4. Brock, Dan; Daniels, Norman; and Wikler, Daniel. 2000. From Chance to Choice: Genetics and Justice. New York: Cambridge University Press.
5. Cooke, Elizabeth. 2003. Germ-Line Engineering, Freedom, and Future Generations. Bioethics 17(1):32-58.
6. Erikson, Robert. 2001. Why Do Graduates Live Longer? Education, Occupation, Family and Mortality during the 1990s. In Cradle to Grave: Life-Course Change in Modern Sweden, ed. Jan O. Jonsson and Colin Mill, pp. 211-27. Durham, U. K.: Sociology Press.
7. Farrelly, Colin. 2008. Genetic Justice Must Track Genetic Complexity. Cambridge Quarterly of Healthcare Ethics 17:45-53.
8. Financial Trend Forecaster. 2008. InfationData.com. Madison Heights, VA: Capital Professional Services. Available at http://www.infationdata.com/ Infation/Consumer-Price-Index/HistoricalCPI.aspx, accessed 23 April 2010.
9. Flaig, Gebhard, and Stadler, Manfred. 1994. Success Breeds Success: The Dynamics of the Innovation Process. Empirical Economics 19:55-68.
10. Fukuyama, Francis. 2002a. How to Regulate Science. Public Interest, no. 146, Winter: 3-22.
11. 2002b. Our Posthuman Future: Consequences of the Biotechnology Revolution. New York: Farrar, Straus and Giroux.
12. Gert, Bernard; Culver, Charles M.; Clouser, Danner K. 2006. Bioethics: A Systematic Approach. 2d ed. New York: Oxford University Press.
13. Green, Ronald M. 2007. Babies by Design: The Ethics of Genetic Choice. New Haven, CT: Yale University Press.
14. Babies by Design: The Ethics of Genetic Choice. BioNews 441 (21 January). Available at http://www.bionews.org.uk/page-37971.asp, accessed 23 April 2010.
15. Greenwood, Jeremy, and Kopecky, Karen. 2007. Measuring the Welfare Gain from Personal Computers. NBER Working Paper Series, no. 13592. Available at http://www.nber.org/papers/w13592.pdf, accessed 23 April 2010.
16. Grossman, Gene M., and Helpman, Elhanan 1989. Endogenous Product Cycles. NBER Working Paper Series, no. 2913. Available at http://www.nber.org/papers/ w2913.pdf, accessed 23 April 2010.
17. Quality Ladders in the Theory of Growth. Review of Economic Studies 58:43-61.
18. Harmon, Amy. 2008. Gene Map Becomes a Luxury Item. New York Times (4 March).
19. Intel. 2005. Moore's Law 40th Anniversary Press Kit. Santa Clara, CA: Intel. Available at: http://www.intel.com/pressroom/kits/events/moores-law-40th/ , accessed 30 April 2010.
20. Juengst, Eric. 1997. Can Enhancement Be Distinguished from Prevention in Genetic Medicine? Journal of Medicine and Philosophy 22:12-142.
21. Krugman, Paul. 1979. A Model of Innovation, Technology Transfer, and the World Distribution of Income. Journal of Political Economy 87:253-66.
22. Rethinking International Trade. Cambridge, MA: MIT Press.
23. Levin, Richard. 1988. Appropriability, R&D Spending, and Technological Performance. American Economic Review 78:424-28.
24. Lewens, Tim. 2001. Development Aid: On Ontogeny and Ethics. Studies in History and Philosophy of Biological and Biomedical Sciences 33:195-217.
25. Mehlman, Maxwell. 2003. Wondergenes: Genetic Enhancement and the Future of Society. Bloomington: Indiana University Press.
26. Genetic Enhancement: Plan Now to Act Later. Kennedy Institute of Ethics Journal 15:77-82.
27. and Botkin, Jeffrey. 1998. Access to the Genome: The Challenge to Equality. Washington, DC: Georgetown University Press.
28. Moore, Adam. 2000. Owning Genetic Information and Gene Enhancement Techniques: Why Privacy and Property Rights May Undermine Social Control of the Human Genome. Bioethics 14(2):97-119.
29. Moore, Gordon. 1965. Cramming More Components onto Integrated Circuits. Electronics 38 (8, 19 April). Available at ftp://download.intel.com/museum/ Moores-Law/Articles-Press-Releases/Gordon-Moore-1965-Article.pdf, accessed 23 April 2010.
30. Romer, Paul. 1990. Endogenous Technological Change. Journal of Political Economy 98(5):S71-S102.
31. Sandel, Michael. 2007. The Case Against Perfection: Ethics in an Age of Genetic Engineering. Cambridge, MA: Harvard University Press.
32. The Economist. 2007. Flood, Famine, and Mobile Phones. Economist, print edition (26 July). Available at http://www.economist.com/world/international/ displaystory.cfm?story-id=9546242, accessed 23 April 2010.
33. Wadman, Meredith. 2008. James Watson's Genome Sequenced at High Speed. Nature 452:788.
34. Wilkinson, Richard, and Pickett, Kate. 2009. The Spirit Level: Why More Equal Societies Almost Always Do Better. New York: Bloomsbury Press.
35. WHO. World Health Organization. 2007. Interim Statement of the Commission on the Social Determinants of Health 2007: Achieving Health Equity: From Root Causes to Fair Outcome. Geneva, Switzerland: WHO. Available at http://whqlibdoc.who.int/publications/2007/interim-statement-eng.pdf, accessed 23 April 2010.